Coronary; Ischemic

3

Review clinical trials related to Coronary; Ischemic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

iCorMicA - Stratified Medicine in Angina

The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: NHS Greater Glasgow and ClydeUpdated: Apr 9, 2026Locations: 39
Eligibility criteria

Age ≥18 years. [+4]

A non-coronary primary indication for invasive angiography (e.g. valve disease,... [+3]

Status: Recruiting

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

Participants needed: 300
Trial details
Age: 40+Biological sex: AllType: ObservationalSponsor: Genetesis Inc.Updated: Feb 20, 2025Locations: 2
Eligibility criteria

Willing to provide informed consent [+3]

Patients unable to fit into CardioFlux device. [+4]

Status: Recruiting

Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)

In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.

Participants needed: 4,200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Insel Gruppe AG, University Hospital BernUpdated: Oct 18, 2024Locations: 1Duration: 10 Years
Eligibility criteria

Adult individual >18 years [+2]

None